Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

5,136 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses.
Mandula JK, Chang S, Mohamed E, Jimenez R, Sierra-Mondragon RA, Chang DC, Obermayer AN, Moran-Segura CM, Das S, Vazquez-Martinez JA, Prieto K, Chen A, Smalley KSM, Czerniecki B, Forsyth P, Koya RC, Ruffell B, Cubillos-Ruiz JR, Munn DH, Shaw TI, Conejo-Garcia JR, Rodriguez PC. Mandula JK, et al. Among authors: chang dc. Cancer Cell. 2022 Aug 29:S1535-6108(22)00380-4. doi: 10.1016/j.ccell.2022.08.016. Online ahead of print. Cancer Cell. 2022. PMID: 36150390
Looking back and what lies ahead.
Chang D. Chang D. HeartRhythm Case Rep. 2022 Sep 15;8(9):660. doi: 10.1016/j.hrcr.2022.08.001. eCollection 2022 Sep. HeartRhythm Case Rep. 2022. PMID: 36147712 Free PMC article. No abstract available.
Neoadjuvant chemotherapy is associated with altered immune cell infiltration and an anti-tumorigenic microenvironment in resected pancreatic cancer.
Dias Costa A, Väyrynen SA, Chawla A, Zhang J, Väyrynen JP, Lau MC, Williams HL, Yuan C, Morales-Oyarvide V, Elganainy D, Singh H, Cleary JM, Perez K, Ng K, Freed-Pastor W, Mancias JD, Dougan SK, Wang J, Rubinson DA, Dunne RF, Kozak MM, Brais L, Reilly E, Clancy T, Linehan DC, Chang DT, Hezel AF, Koong AC, Aguirre A, Wolpin BM, Nowak JA. Dias Costa A, et al. Among authors: chang dt. Clin Cancer Res. 2022 Sep 21:CCR-22-1125. doi: 10.1158/1078-0432.CCR-22-1125. Online ahead of print. Clin Cancer Res. 2022. PMID: 36129461
5,136 results